Intrinsic Value of S&P & Nasdaq Contact Us

ICU Medical, Inc. ICUI NASDAQ

NASDAQ Global Select • Healthcare • Medical - Instruments & Supplies • US • USD

SharesGrow Score
44/100
1/7 Pass
SharesGrow Intrinsic Value
$462.61
+266.5%
Analyst Price Target
$179.00
+41.8%

ICU Medical, Inc. (ICUI) generated $60.6M in operating cash flow for quarter ending 2025-12-31. After capital expenditures of $24.65M, free cash flow was $35.95M.

Free cash flow margin was 6.7% of revenue. Cash conversion ratio was -3.85x, suggesting some earnings are non-cash.

The company returned $8.77M in share buybacks to shareholders during the quarter.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (60/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was -3.85x suggests some earnings are non-cash items

Overall SharesGrow Score: 44/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
44/100
SG Score
View full scorecard →
VALUE
31/100
Price-to-Earnings & upside
→ Valuation
FUTURE
94/100
Analyst consensus
→ Forecast
PAST
25/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
60/100
Proven by this page
GROWTH
15/100
→ Income
INCOME
30/100
→ Income
ICU Medical, Inc. Cash Flow History
Metric TTM Q4 FY2025 Q3 FY2025 Q2 FY2025 Q1 FY2025
Operating Cash Flow $179.85M$60.6M$56.71M$11.21M$51.33M
Capital Expenditure $-90.35M$-24.65M$-29.08M$-22.01M$-14.62M
Free Cash Flow $89.5M$35.95M$27.63M$-10.79M$36.71M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message